Anti-inflammatory cytokines in autism spectrum disorders: A systematic review and meta-analysis

Cytokine

Volumn 123, Issue , 2019, Pages

  Saghazadeh, Amene ^a,b   Ataeinia, Bahar ^a,b   Keynejad, Kimia ^b   Abdolalizadeh, Amirhussein ^a,c   Hirbod Mobarakeh, Armin ^f   Rezaei, Nima ^a,d,e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSAL SCIENTIFIC EDUCATION AND RESEARCH NETWORK USERN   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Malignancy and Autoimmunity (NIIMA)   (United States)

^f IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autism; Cytokine; Inflammation; Latitude; Meta analysis; Systematic review

Indexed keywords

ALPHA INTERFERON; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; TRANSFORMING GROWTH FACTOR BETA;

AGE; ANTIINFLAMMATORY ACTIVITY; AUTISM; CONCENTRATION (PARAMETER); EFFECT SIZE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; LATITUDE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; BLOOD; IMMUNOLOGY; INFLAMMATION; META ANALYSIS;

AUTISM SPECTRUM DISORDER; CYTOKINES; HUMANS; INFLAMMATION;

EID: 85067417334     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2019.154740     Document Type: Review

References (68)

1. Kronfol, Z., Remick, D.G., Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry 157:5 (2000), 683–694.
2. Zhu, C.-B., Blakely, R.D., Hewlett, W.A., The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacol.: Off. Publ. Am. College Neuropsychopharmacol., 31(10), 2006, 2121.
3. Raison, C.L., Borisov, A.S., Woolwine, B.J., Massung, B., Vogt, G., Miller, A.H., Interferon-α effects on diurnal hypothalamic–pituitary–adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol. Psychiatry, 15(5), 2010, 535.
4. Dowlati, Y., Herrmann, N., Swardfager, W., et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 67:5 (2010), 446–457.
5. Miller, B.J., Buckley, P., Seabolt, W., Mellor, A., Kirkpatrick, B., Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 70:7 (2011), 663–671.
6. Modabbernia, A., Taslimi, S., Brietzke, E., Ashrafi, M., Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol. Psychiatry 74:1 (2013), 15–25.
7. Grzadzinski, R., Huerta, M., Lord, C., DSM-5 and autism spectrum disorders (ASDs): an opportunity for identifying ASD subtypes. Mol. Autism, 4(1), 2013, 12.
8. Russell, J., Jarrold, C., Henry, L., Working memory in children with autism and with moderate learning difficulties. J. Child Psychol. Psychiatry 37:6 (1996), 673–686.
9. Kotagal, S., Broomall, E., Sleep in children with autism spectrum disorder. Pediatr. Neurol. 47:4 (2012), 242–251.
10. Hill, A.P., Zuckerman, K.E., Hagen, A.D., et al. Aggressive behavior problems in children with autism spectrum disorders: prevalence and correlates in a large clinical sample. Res. Autism Spectrum Disord. 8:9 (2014), 1121–1133.
11. Leyfer, O.T., Folstein, S.E., Bacalman, S., et al. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J. Autism Dev. Disord. 36:7 (2006), 849–861.
12. Masi, A., Quintana, D.S., Glozier, N., Lloyd, A.R., Hickie, I.B., Guastella, A.J., Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol. Psychiatry 20:4 (2015), 440–446.
13. Saghazadeh, A., Rezaei, N., Systematic review and meta-analysis links autism and toxic metals and highlights the impact of country development status: Higher blood and erythrocyte levels for mercury and lead, and higher hair antimony, cadmium, lead, and mercury. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 79 (2017), 340–368.
14. Saghazadeh, A., Mahmoudi, M., Meysamie, A., Gharedaghi, M., Zamponi, G.W., Rezaei, N., Possible role of trace elements in epilepsy and febrile seizures: a meta-analysis. Nutr. Rev. 73:11 (2015), 760–779.
15. Saghazadeh, A., Gharedaghi, M., Meysamie, A., Bauer, S., Rezaei, N., Proinflammatory and anti-inflammatory cytokines in febrile seizures and epilepsy: systematic review and meta-analysis. Rev. Neurosci. 25:2 (2014), 281–305.
16. Agah, E., Zardoui, A., Saghazadeh, A., Ahmadi, M., Tafakhori, A., Rezaei, N., Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis. PLoS One, 13(1), 2018, e0190252.
17. Saghazadeh, A., Ahangari, N., Hendi, K., Saleh, F., Rezaei, N., Status of essential elements in autism spectrum disorder: systematic review and meta-analysis. Rev. Neurosci. 28:7 (2017), 783–809.
18. Rezaei, S., Abdurahman, A.A., Saghazadeh, A., Badv, R.S., Mahmoudi, M., Short-term and long-term efficacy of classical ketogenic diet and modified Atkins diet in children and adolescents with epilepsy: a systematic review and meta-analysis. Nutritional Neurosci., 2017, 1–18.
19. Saghazadeh, A., Rezaei, N., Brain-derived neurotrophic factor levels in autism: a systematic review and meta-analysis. J. Autism Dev. Disord. 47:4 (2017), 1018–1029.
20. Saghazadeh, A., Mahmoudi, M., Ashkezari, A.D., Rezaie, N.O., Rezaei, N., Systematic review and meta-analysis shows a specific micronutrient profile in people with Down Syndrome: lower blood calcium, selenium and zinc, higher red blood cell copper and zinc, and higher salivary calcium and sodium. PLoS One, 12(4), 2017, e0175437.
21. Harsini, S., Saghazadeh, A., Nedjat, S., Rezaei, N., Associations between interleukin-10 polymorphisms and susceptibility to juvenile idiopathic arthritis: a systematic review and meta-analysis. Eur. Cytokine Netw. 29:1 (2018), 16–26.
22. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Prisma, G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med., 6(7), 2009, e1000097.
23. Higgins JPT GSe. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org.
24. Stang, A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25:9 (2010), 603–605.
25. Higgins, J.P.T., Green, S., Handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011]. Cochrane Collaborat., 2011.
26. Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994, 1088–1101.
27. Duval, S., Tweedie, R., Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:2 (2000), 455–463.
28. Duval, S., Tweedie, R., Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:2 (2000), 455–463.
29. Zimmerman, A.W., Jyonouchi, H., Comi, A.M., et al. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr. Neurol. 33:3 (2005), 195–201.
30. Xie, J., Huang, L., Li, X., et al. Immunological cytokine profiling identifies TNF-α as a key molecule dysregulated in autistic children. Oncotarget 8:47 (2017), 82390–82398.
31. Tostes, M.H.F.S., Teixeira, H.C., Gattaz, W.F., Brandão, M.A.F., Raposo, N.R.B., Altered neurotrophin, neuropeptide, cytokines and nitric oxide levels in autism. Pharmacopsychiatry 45:6 (2012), 241–243.
32. Tobiasova, Z., van der Lingen, K.H., Scahill, L., et al. Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. J. Child Adolesc. Psychopharmacol. 21:6 (2011), 555–564.
33. Suzuki, K., Matsuzaki, H., Iwata, K., et al. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One, 6(5), 2011, e20470.
34. Singh, V.K., Warren, R.P., Odell, J.D., Cole, P., Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin. Immunol. Immunopathol. 61:3 (1991), 448–455.
35. Singh, V.K., Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J. Neuroimmunol. 66:1–2 (1996), 143–145.
36. Ricci, S., Businaro, R., Ippoliti, F., et al. Altered cytokine and BDNF levels in autism spectrum disorder. Neurotox. Res. 24:4 (2013), 491–501.
37. Pecorelli, A., Cervellati, F., Belmonte, G., et al. Cytokines profile and peripheral blood mononuclear cells morphology in Rett and autistic patients. Cytokine 77 (2016), 180–188.
38. Pardo, C.A., Farmer, C.A., Thurm, A., et al. Serum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal study. Mol. Autism, 8, 2017, 1.
39. Okada, K., Hashimoto, K., Iwata, Y., et al. Decreased serum levels of transforming growth factor-β1 in patients with autism. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 31:1 (2007), 187–190.
40. Napolioni, V., Ober-Reynolds, B., Szelinger, S., et al. Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder. J. Neuroinflammat., 10, 2013, 38.
41. Manzardo, A.M., Henkhaus, R., Dhillon, S., Butler, M.G., Plasma cytokine levels in children with autistic disorder and unrelated siblings. Int. J. Develop. Neurosci.: Off. J. Int. Soc. Develop. Neurosci. 30:2 (2012), 121–127.
42. Jacome, M.C.I., Chacon, L.M.M., Cuesta, H.V., et al. Peripheral inflammatory markers contributing to comorbidities in autism. Behavioral Sci., 6(4), 2016.
43. Hashim, H., Abdelrahman, H., Mohammed, D., Karam, R., Association between plasma levels of transforming growth factor-β1, IL-23 and IL-17 and the severity of autism in Egyptian children. Res. Autism Spectrum Disord. 7:1 (2013), 199–204.
44. Han, Y.M.Y., Cheung, W.K.Y., Wong, C.K., et al. Distinct cytokine and chemokine profiles in autism spectrum disorders. Front. Immunol, 8(JAN), 2017.
45. Guloksuz, S.A., Abali, O., Cetin, E.A., et al. Elevated plasma concentrations of S100 calcium-binding protein B and tumor necrosis factor alpha in children with autism spectrum disorders. Revista Brasileira de Psiquiatria 39:3 (2017), 195–200.
46. Emanuele, E., Orsi, P., Boso, M., et al. Low-grade endotoxemia in patients with severe autism. Neurosci. Lett. 471:3 (2010), 162–165.
47. El-Ansary, A., Hassan, W.M., Qasem, H., Das, U.N., Identification of Biomarkers of Impaired Sensory Profiles among Autistic Patients. PLoS One, 11(11), 2016, e0164153.
48. El-Ansary, A., Al-Ayadhi, L., Neuroinflammation in autism spectrum disorders. J. Neuroinflammat., 9, 2012, 265.
49. El Gohary, T.M., El Aziz, N.A., Darweesh, M., Sadaa, E.S., Plasma level of transforming growth factor β 1 in children with autism spectrum disorder. Egypt. J. Ear Nose Throat Allied Sci. 16:1 (2015), 69–73.
50. Croonenberghs, J., Bosmans, E., Deboutte, D., Kenis, G., Maes, M., Activation of the inflammatory response system in autism. Neuropsychobiology 45:1 (2002), 1–6.
51. Bryn, V., Aass, H.C.D., Skjeldal, O.H., Isaksen, J., Saugstad, O.D., Ormstad, H., Cytokine profile in autism spectrum disorders in children. J. Mol. Neurosci., 61(1), 2017.
52. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J, Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 25:1 (2011), 40–45.
53. Ashwood, P., Enstrom, A., Krakowiak, P., et al. Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J. Neuroimmunol. 204:1–2 (2008), 149–153.
54. Denney, D.R., Frei, B.W., Gaffney, G.R., Lymphocyte subsets and interleukin-2 receptors in autistic children. J. Autism Dev. Disord. 26:1 (1996), 87–97.
55. Ashwood, P., Anthony, A., Torrente, F., Wakefield, A.J., Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: Mucosal immune activation and reduced counter regulatory interleukin-10. J. Clin. Immunol. 24:6 (2004), 664–673.
56. Ashwood, P., Wakefield, A.J., Immune activation of peripheral blood and mucosal CD3(+) lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol. 173:1–2 (2006), 126–134.
57. Jyonouchi, H., Geng, L., Ruby, A., Zimmerman-Bier, B., Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 51:2 (2005), 77–85.
58. Heuer, L., Braunschweig, D., Ashwood, P., Van de Water, J., Campbell, D.B., Association of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression. Transl. Psychiatry, 1, 2011.
59. Abdallah, M.W., Larsen, N., Mortensen, E.L., et al. Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank. J. Neuroimmunol. 252:1–2 (2012), 75–82.
60. Abdallah, M.W., Larsen, N., Grove, J., et al. Amniotic fluid inflammatory cytokines: Potential markers of immunologic dysfunction in autism spectrum disorders. World J. Biol. Psychiatry 14:7 (2013), 528–538.
61. Li, X.H., Chauhan, A., Sheikh, A.M., et al. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 207:1–2 (2009), 111–116.
62. Meyer, U., Murray, P.J., Urwyler, A., Yee, B.K., Schedlowski, M., Feldon, J., Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol. Psychiatry, 13(2), 2008, 208.
63. Mandal, M., Marzouk, A.C., Donnelly, R., Ponzio, N.M., Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells. Brain Behav. Immun. 25:5 (2011), 863–871.
64. Patterson, P.H., Maternal infection and immune involvement in autism. Trends Mol. Med. 17:7 (2011), 389–394.
65. Molloy, C.A., Morrow, A.L., Meinzen-Derr, J., et al. Elevated cytokine levels in children with autism spectrum disorder. J. Neuroimmunol. 172:1–2 (2006), 198–205.
66. Rose, D.R., Yang, H., Serena, G., et al. Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms. Brain Behav. Immun., 2018.
67. Goines, P.E., Croen, L.A., Braunschweig, D., et al. Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: a case-control study. Mol. Autism, 2(1), 2011.
68. Choi, J.E., Widjaja, F., Careaga, M., Bent, S., Ashwood, P., Hendren, R.L., Change in plasma cytokine levels during risperidone treatment in children with autism. J. Child Adolesc. Psychopharmacol. 24:10 (2014), 586–589.